Tricyclic antidepressants and selective serotonin reuptake inhibitors (SSRIs) may improve cataplexy. With respect to antidepressants both selective serotonin reuptake inhibitors and tricyclic antidepressants appear useful. Benzodiazepines also function as weak adenosine reuptake inhibitors. Some medications such as selective serotonin reuptake inhibitors (SSRIs) affect IELT. Pharmaceutical treatments for GAD include selective serotonin reuptake inhibitors (SSRIs). ACE inhibitors, and angiotensin receptor blockers. Aripiprazole may interact with some antidepressants, especially selective serotonin reuptake inhibitors (SSRIs). It interacts with monoamine oxidase inhibitors. Resistance to some protease inhibitors is high. There are four kinds of reversible enzyme inhibitors. Antidepressants of the selective serotonin reuptake inhibitors (SSRI) class may have a modest benefit. It is generally less preferred than selective serotonin reuptake inhibitors (SSRIs). Disinhibition and compulsive behaviors can be controlled by selective serotonin reuptake inhibitors (SSRIs). Cyclobenzaprine has major contraindications with monoamine oxidase inhibitors (MAOIs). These include AR antagonists, androgen synthesis inhibitors, and antigonadotropins.